Robert J Gould's Net Worth
$19.5 Million
Who is Robert J Gould?
Robert J Gould has an estimated net worth of $19.5 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Epizyme, Inc., and Turnstone Biologics Corp..
SEC CIK
Robert J Gould's CIK is 0001577034
Past Insider Trading and Trends
2014 was Robert J Gould's most active year for acquiring shares with 14 total transactions. Robert J Gould's most active month to acquire stocks was the month of May. 2014 was Robert J Gould's most active year for disposing of shares, totalling 31 transactions. Robert J Gould's most active month to dispose stocks was the month of May. 2022 saw Robert J Gould paying a total of $1,865,441.76 for 256,939 shares, this is the most they've acquired in one year. In 2014 Robert J Gould cashed out on 630,000 shares for a total of $8,683,890.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.99
Interim President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
| -1.34% | -6.77K |
$15.00 | -$101,490.00 | 499.86K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
$7.97 | -$17,844.46 | 506.63K |
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
$7.92 | -$10,493.46 | 506.63K |
Scheduled
|
Jun 2 - Jun 6
| ||
Form 4
|
—
|
0
|
$15.93 | -$91,081.42 | 506.63K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$16.00 | -$1,537,755.87 | 506.63K |
Scheduled
|
Apr 1 - Apr 5
| ||
Form 4
| -1.94% | -10.00K |
$12.16 | -$121,578.33 | 506.63K |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
| -1.57% | -8.21K |
$14.27 | -$117,197.40 | 516.63K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| -1.87% | -10.00K |
$12.08 | -$120,826.00 | 524.85K |
Scheduled
|
Jan 20
| ||
Form 4
| -0.47% | -2.50K |
$20.00 | -$50,000.00 | 534.85K |
Scheduled
|
Jul 8
| ||
Form 4
| -0.46% | -2.50K |
$20.80 | -$51,992.00 | 537.35K |
Scheduled
|
Jun 25
| ||
Form 4
| -0.03% | -156.00 |
$20.00 | -$3,120.00 | 539.85K |
Scheduled
|
Jun 9
| ||
Form 4
| -0.63% | -3.43K |
$20.17 | -$69,251.16 | 540K |
Scheduled
|
Jun 5
| ||
Form 4
| -0.51% | -2.80K |
$20.09 | -$56,250.43 | 543.43K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
| -0.51% | -2.80K |
$20.00 | -$56,040.00 | 546.23K |
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -0.60% | -3.31K |
$20.04 | -$66,301.91 | 549.04K |
Scheduled
|
May 28 - May 29
| ||
Form 4
| -0.45% | -2.50K |
$20.00 | -$50,000.00 | 552.35K |
Scheduled
|
May 26
| ||
Form 4
| -0.45% | -2.50K |
$20.00 | -$50,000.00 | 554.85K |
Scheduled
|
Feb 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$9.26 | -$561,956.49 |
0
|
Scheduled
|
Dec 29 - Dec 30
| ||
Form 4
|
—
|
0
|
$10.19 | -$1,161,142.28 |
0
|
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$11.24 | -$1,287,754.02 |
0
|
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$11.87 | -$1,362,480.08 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
$12.73 | -$733,323.37 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$13.40 | -$773,000.30 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$16.99 | -$988,600.58 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$15.38 | -$891,956.24 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$16.02 | -$930,495.36 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$11.36 | -$650,760.24 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$11.21 | -$642,137.77 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$10.37 | -$591,438.00 |
0
|
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$14.88 | -$1,724,400.00 |
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$10.25 | -$594,654.27 |
0
|
Scheduled
|
Jan 2
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Turnstone Biologics Corp. (TSBX) Snapshot price: $2.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||